相关实验视频

Updated: Jun 13, 2025

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

在法布里病中确定治疗有效性:基于观察的改善建议

Bram C F Veldman¹, Daphne H Schoenmakers^2,3, Laura van Dussen¹

¹Department of Endocrinology and Metabolism, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.

International journal of molecular sciences

|September 14, 2024

概括

为法布里病 (FD) 疗法建立强有力的证据是具有挑战性的,因为患者的变化和研究设计的局限性. 未来的研究需要患者匹配,国际合作和标准化的结果措施,以有效评估治疗.

科学领域:

遗传学和罕见疾病.
酶替代疗法是一种酶替代疗法.
药理学药理学是指药理学的学科.

背景情况:

费布里病 (FD) 源于致病性*GLA*基因变异,导致α-银酸酶A缺乏和基质积累.
FD在性别和疾病阶段之间呈现出高度可变的表型,使临床评估复杂化.
尽管有20年的治疗方法,但长期有效性的强有力的证据仍然难以捉摸.

研究的目的:

确定阻碍FD疗法的强有力的证据生成的因素.
提出提高未来FD治疗研究质量和可靠性的策略.

主要方法:

关于法布里病治疗的现有文献的审查,重点是酶替代疗法 (ERT) 和陪伴者疗法.
分析导致研究群体和设计异质性的因素.
确定结果评估和研究持续时间的局限性.

主要成果:

主要挑战包括患者群体 (性别,年龄,表型,疾病阶段) 的显著异质性以及研究设计的变化 (对照组,结果测量,研究持续时间).
这些因素共同阻碍了建立强有力的证据来证明FD治疗的长期有效性.

结论:

倡导患者匹配,以提高对照组在未来的FD治疗研究中的可比性.
建议通过一个独立的FD登记册进行国际合作和协调.
提出一个逐步的方法来评估新的治疗方法,包括替代结果和定义的研究持续时间.

关键词:

费布里病是什么意思费布里病是什么意思陪伴者治疗是一种陪伴疗法.临床结果的临床结果.酶替代疗法 (ERT) 是一种酶替代疗法.治疗的有效性治疗的有效性.

更多相关视频

Home-Based Monitor for Gait and Activity Analysis

Home-Based Monitor for Gait and Activity Analysis

Published on: August 8, 2019

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...